About HATIP

A regular electronic newsletter for health care workers and community-based organisations on HIV treatment in resource-limited settings.

Its publication is supported by the UK government's Department for International Development (DfID), the Diana, Princess of Wales Memorial Fund and the Stop TB Department of the World Health Organization.

Other supporters include Positive Action GlaxoSmithKline (founding sponsor); Abbott Fund; Abbott Molecular; Cavidi; Elton John AIDS Foundation; Merck & Co., Inc.; Pfizer Ltd; F Hoffmann La Roche; Schering Plough; and Tibotec, a division of Janssen Cilag.

latest aidsmap news

• HIV/TB epidemic in Eastern Europe a 'public health disaster'
• Low bone mineral density common in HIV-positive men
• Circumcision may protect HIV-negative gay men from syphilis
• HIV 'exposure' from bite forms basis for terrorism charge in US case
• First hint of a hepatitis C vaccine?
• Pregnancy, not nevirapine cause of liver toxicities in HIV-positive women
• Surviving to die of something else: AIDS is a rare cause of death in old people with HIV
• New EACS guidelines address co-morbidities and diseases of age
• Small case series looks at etravirine during pregnancy
• Protease inhibitor monotherapy as a maintenance regimen: are we edging towards acceptance?